Evidence map›Paper›PMID 34852683›Full record

ArticleJournal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc2022

Receptor-binding domain-based immunoassays for serosurveillance differentiate efficiently between SARS-CoV2-exposed and non-exposed farmed mink.

Jorge Pulido, Marga García-Durán, Ricardo Fernández-Antonio, Carmen Galán, Lissette López, Carmen Vela, Ángel Venteo, Paloma Rueda, Luis A Rivas

Open access · bronzeAbstract read
In one paragraph

Article in Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Jorge PulidoDepartments of R&D, Eurofins-Ingenasa, Madrid, Spain.
Marga García-DuránDepartments of R&D, Eurofins-Ingenasa, Madrid, Spain.
Ricardo Fernández-AntonioDepartment of Animal Health, Galician Mink Breeders Association (AGAVI), Santiago de Compostela, Spain.
Carmen GalánMolecular Diagnostics, Eurofins-Ingenasa, Madrid, Spain.
Lissette LópezDepartments of R&D, Eurofins-Ingenasa, Madrid, Spain.
Carmen VelaDepartments of R&D, Eurofins-Ingenasa, Madrid, Spain.ORCID https://orcid.org/0000-0002-0791-5735
Ángel VenteoDepartments of R&D, Eurofins-Ingenasa, Madrid, Spain.
Paloma RuedaDepartments of R&D, Eurofins-Ingenasa, Madrid, Spain.
Luis A RivasDepartments of R&D, Eurofins-Ingenasa, Madrid, Spain.ORCID https://orcid.org/0000-0001-8392-3000
Ingenasa (Spain) · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During the COVID-19 pandemic, infection of farmed mink has become not only an economic issue but also a widespread public health concern. International agencies have advised the use of strict molecular and serosurveillance methods for monitoring the SARS-CoV2 status on mink farms. We developed 2 ELISAs and a duplex protein microarray immunoassay (MI), all in a double-recognition format (DR), to detect SARS-CoV2 antibodies specific to the receptor-binding domain (RBD) of the spike protein and to the full-length nucleoprotein (N) in mink sera. We collected 264 mink serum samples and 126 oropharyngeal samples from 5 Spanish mink farms. In both of the ELISAs and the MI, RBD performed better than N protein for serologic differentiation of mink from SARS-CoV2-positive and -negative farms. Therefore, RBD was the optimal antigenic target for serosurveillance of mink farms.

Indexed as

COVID-19MinkAnimalsAntibodies, ViralFarmsImmunoassayPandemicsRNA, ViralSARS-CoV-2Spike Glycoprotein, CoronavirusAntibodies, ViralRNA, ViralSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2COVID-19ELISAminkprotein microarrayRBDSARS-CoV2serosurveillance

Identifiers

PMID34852683
PMCPMC8921823
OpenAlexW3216057809

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.